{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:05:59Z","timestamp":1779264359623,"version":"3.51.4"},"reference-count":58,"publisher":"China Science Publishing & Media Ltd.","issue":"5","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.3724\/abbs.2026055","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:35:36Z","timestamp":1773905736000},"page":"1155-1169","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Atractylenolide I mitigates Alzheimer\u2019s disease                     pathology in ApoE<sup>\u2013\/\u2013<\/sup> mice via ARG1\/nNOS axis and lipid homeostasis                     regulation"],"prefix":"10.3724","volume":"58","author":[{"given":"Xun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(04)15900-X","volume":"363","author":"Casserly I","year":"2004","unstructured":"Casserly I, Topol EJ. Convergence of atherosclerosis and Alzheimer\u2019s disease:                         inflammation, cholesterol, and misfolded proteins. Lancet, 2004, 363: 1139-1146.","journal-title":"Lancet"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41593-020-0635-5","volume":"23","author":"Wingo AP","year":"2020","unstructured":"Wingo AP, Fan W, Duong DM, Gerasimov ES, Dammer EB, Liu Y, Harerimana NV. Shared proteomic effects of cerebral atherosclerosis and                         Alzheimer\u2019s disease on the human brain. Nat Neurosci, 2020, 23: 696-700.","journal-title":"Nat Neurosci"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2318-14-36","volume":"14","author":"Lathe R","year":"2014","unstructured":"Lathe R, Sapronova A, Kotelevtsev Y. Atherosclerosis and Alzheimer-diseases with a common cause?                         Inflammation, oxysterols, vasculature. BMC Geriatr, 2014, 14: 36.","journal-title":"BMC Geriatr"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"Mahley RW","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding                         role in cell biology. Science, 1988, 240: 622-630.","journal-title":"Science"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"Bell RD","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM. Apolipoprotein E controls cerebrovascular integrity via                         cyclophilin A. Nature, 2012, 485: 512-516.","journal-title":"Nature"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"Holtzman DM","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology                         and roles in alzheimer disease. Cold Spring                             Harb Perspect Med, 2012, 2: a006312.","journal-title":"Cold Spring                             Harb Perspect Med"},{"key":"CITATION7","doi-asserted-by":"crossref","unstructured":"Berislav V Z. Cerebrovascular effects of apolipoprotein E:                         implications for Alzheimer disease.                              JAMA                         Neurol                          2013, 70: 440\u2013444.","DOI":"10.1001\/jamaneurol.2013.2152"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/S0002-9440(10)63572-9","volume":"163","author":"Li L","year":"2003","unstructured":"Li L, Cao D, Garber DW, Kim H, Fukuchi K. Association of aortic atherosclerosis with cerebral \u03b2-amyloidosis                         and learning deficits in a mouse model of Alzheimer\u2032s disease. Am J Pathol, 2003, 163: 2155-2164.","journal-title":"Am J Pathol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1038\/s41380-022-01556-0","volume":"27","author":"Liao J","year":"2022","unstructured":"Liao J, Chen G, Liu X, Wei ZZ, Yu SP, Chen Q, Ye K. C\/EBP\u03b2\/AEP signaling couples atherosclerosis to the pathogenesis                         of Alzheimer\u2019s disease. Mol Psychiatry, 2022, 27: 3034-3046.","journal-title":"Mol Psychiatry"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12016-021-08909-7","volume":"64","author":"Bleve A","year":"2023","unstructured":"Bleve A, Motta F, Durante B, Pandolfo C, Selmi C, Sica A. Immunosenescence, inflammaging, and frailty: role of myeloid                         cells in age-related diseases. Clinic Rev                             Allerg Immunol, 2023, 64: 123-144.","journal-title":"Clinic Rev                             Allerg Immunol"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1161\/01.CIR.0000041433.94868.12","volume":"106","author":"Uzui H","year":"2002","unstructured":"Uzui H, Harpf A, Liu M, Doherty TM, Shukla A, Chai NN, Tripathi PV. Increased expression of membrane type 3-matrix metalloproteinase                         in human atherosclerotic plaque. Circulation, 2002, 106: 3024-3030.","journal-title":"Circulation"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"101501","DOI":"10.1016\/j.redox.2020.101501","volume":"32","author":"Yang Y","year":"2020","unstructured":"Yang Y, Wang J, Guo S, Pourteymour S, Xu Q, Gong J, Huang Z. Non-lethal sonodynamic therapy facilitates the M1-to-M2                         transition in advanced atherosclerotic plaques via activating the                         ROS-AMPK-mTORC1-autophagy pathway. Redox Biol, 2020, 32: 101501.","journal-title":"Redox Biol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","volume":"29","author":"Mantovani A","year":"2009","unstructured":"Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis. Arterioscler                             Thromb Vasc Biol, 2009, 29: 1419-1423.","journal-title":"Arterioscler                             Thromb Vasc Biol"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fimmu.2015.00370","volume":"6","author":"Hume DA","year":"2015","unstructured":"Hume DA. The many alternative faces of macrophage activation. Front Immunol, 2015, 6: 370.","journal-title":"Front Immunol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm820","volume":"9","author":"Joseph SB","year":"2003","unstructured":"Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by                         liver X receptors. Nat Med, 2003, 9: 213-219.","journal-title":"Nat Med"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2005.06.029","volume":"122","author":"Ogawa S","year":"2005","unstructured":"Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A. Molecular determinants of crosstalk between nuclear receptors and                         Toll-like receptors. Cell, 2005, 122: 707-721.","journal-title":"Cell"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI27883","volume":"116","author":"Zelcer N","year":"2006","unstructured":"Zelcer N. Liver X receptors as integrators of metabolic and inflammatory                         signaling. J Clin Invest, 2006, 116: 607-614.","journal-title":"J Clin Invest"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"e13651","DOI":"10.7717\/peerj.13651","volume":"10","author":"Solanki K","year":"2022","unstructured":"Solanki K, Rajpoot S, Bezsonov EE, Orekhov AN, Saluja R, Wary A, Axen C. The expanding roles of neuronal nitric oxide synthase (NOS1). PeerJ, 2022, 10: e13651.","journal-title":"PeerJ"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tips.2015.03.006","volume":"36","author":"Caldwell RB","year":"2015","unstructured":"Caldwell RB, Toque HA, Narayanan SP, Caldwell RW. Arginase: an old enzyme with new tricks. Trends                             Pharmacol Sci, 2015, 36: 395-405.","journal-title":"Trends                             Pharmacol Sci"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.exger.2018.12.011","volume":"116","author":"Moretto J","year":"2019","unstructured":"Moretto J, Girard C, Demougeot C. The role of arginase in aging: a systematic review. Exp                             Gerontology, 2019, 116: 54-73.","journal-title":"Exp                             Gerontology"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1161\/01.ATV.17.11.2479","volume":"17","author":"Wilcox JN","year":"1997","unstructured":"Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of nitric oxide synthase in                         normal and atherosclerotic vessels. Arterioscler                             Thromb Vasc Biol, 1997, 17: 2479-2488.","journal-title":"Arterioscler                             Thromb Vasc Biol"},{"key":"CITATION22","unstructured":"Brutsaert DL. The indispensable role of cardiac endothelium in                         the structure and function of the heart.                              Verh K Acad                         Geneeskd Belg                          2003, 65: 75\u2013116."},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1038\/srep03840","volume":"4","author":"Huang JM","year":"2014","unstructured":"Huang JM, Zhang GN, Shi Y, Zha X, Zhu Y, Wang MM, Lin Q. Atractylenolide-I sensitizes human ovarian cancer cells to                         paclitaxel by blocking activation of TLR4\/MyD88-dependent pathway. Sci Rep, 2014, 4: 3840.","journal-title":"Sci Rep"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3109\/08923973.2014.968256","volume":"36","author":"Ji G","year":"2014","unstructured":"Ji G, Chen R, Zheng J. Atractylenolide I inhibits lipopolysaccharide-induced                         inflammatory responses via mitogen-activated protein kinase pathways in                         RAW264.7 cells. Immunopharmacol Immunotoxicol, 2014, 36: 420-425.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yexcr.2017.02.040","volume":"353","author":"Li W","year":"2017","unstructured":"Li W, Zhi W, Liu F, He Z, Wang X, Niu X. Atractylenolide I restores HO-1 expression and inhibits                         Ox-LDL-induced VSMCs proliferation, migration and inflammatory responses in                         vitro. Exp Cell Res, 2017, 353: 26-34.","journal-title":"Exp Cell Res"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ptr.2040","volume":"21","author":"Li CQ","year":"2007","unstructured":"Li CQ, He LC, Jin JQ. Atractylenolide I and atractylenolide III inhibit                         Lipopolysaccharide-induced TNF-\u03b1 and NO production in                         macrophages. PhytoTher Res, 2007, 21: 347-353.","journal-title":"PhytoTher Res"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/nu12020471","volume":"12","author":"Krishnan M","year":"2020","unstructured":"Krishnan M, Hwang JS, Kim M, Kim YJ, Seo JH, Jung J, Ha E. \u03b2-hydroxybutyrate impedes the progression of Alzheimer\u2019s disease                         and atherosclerosis in ApoE-deficient mice. Nutrients, 2020, 12: 471.","journal-title":"Nutrients"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"148518","DOI":"10.1016\/j.brainres.2023.148518","volume":"1819","author":"Babalola JA","year":"2023","unstructured":"Babalola JA, Lang M, George M, Stracke A, Tam-Amersdorfer C, Itxaso I, Lucija D. Astaxanthin enhances autophagy, amyloid beta clearance and exerts                         anti-inflammatory effects in in vitro models of Alzheimer\u2019s disease-related                         blood brain barrier dysfunction and inflammation. Brain Res, 2023, 1819: 148518.","journal-title":"Brain Res"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"653795","DOI":"10.3389\/fphar.2021.653795","volume":"12","author":"Luo Y","year":"2021","unstructured":"Luo Y, Chen H, Tsoi B, Wang Q, Shen J. Danggui-shaoyao-san (DSS) ameliorates cerebral                         ischemia-reperfusion injury via activating SIRT1 signaling and inhibiting                         NADPH oxidases. Front Pharmacol, 2021, 12: 653795.","journal-title":"Front Pharmacol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1338804","DOI":"10.3389\/fphar.2023.1338804","volume":"14","author":"He J","year":"2023","unstructured":"He J, Jin Y, He C, Li Z, Yu W, Zhou J, Luo R. Danggui Shaoyao San: comprehensive modulation of the                         microbiota-gut-brain axis for attenuating Alzheimer\u2019s disease-related                         pathology. Front Pharmacol, 2023, 14: 1338804.","journal-title":"Front Pharmacol"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","volume":"190","author":"Loera-Valencia R","year":"2019","unstructured":"Loera-Valencia R, Goikolea J, Parrado-Fernandez C, Merino-Serrais P, Maioli S. Alterations in cholesterol metabolism as a risk factor for                         developing Alzheimer\u2019s disease: potential novel targets for treatment. J Steroid                             Biochem Mol Biol, 2019, 190: 104-114.","journal-title":"J Steroid                             Biochem Mol Biol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/ADR-210299","volume":"6","author":"Rudge JD","year":"2022","unstructured":"Rudge JD. A new hypothesis for alzheimer\u2019s disease: the lipid invasion                         model. J Alzheimers Dis Rep, 2022, 6: 129-161.","journal-title":"J Alzheimers Dis Rep"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","volume":"11","author":"Nordestgaard LT","year":"2015","unstructured":"Nordestgaard LT, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. Loss-of-function mutation in ABCA1 and risk of                         Alzheimer\u2019s disease and cerebrovascular disease. Alzheimers                             Dement, 2015, 11: 1430-1438.","journal-title":"Alzheimers                             Dement"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12974-017-1005-4","volume":"14","author":"Wu CH","year":"2017","unstructured":"Wu CH, Shyue SK, Hung TH, Wen S, Lin CC, Chang CF, Chen SF. Genetic deletion or pharmacological inhibition of soluble epoxide                         hydrolase reduces brain damage and attenuates neuroinflammation after                         intracerebral hemorrhage. J Neuroinflamm, 2017, 14: 230.","journal-title":"J Neuroinflamm"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s0891-5849(02)01327-8","volume":"34","author":"Stewart VC","year":"2003","unstructured":"Stewart VC, Heales SJR. Nitric oxide-induced mitochondrial dysfunction: implications for                         neurodegeneration. Free Radical                             Biol Med, 2003, 34: 287-303.","journal-title":"Free Radical                             Biol Med"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"828447","DOI":"10.3389\/fimmu.2022.828447","volume":"13","author":"Zhu H","year":"2022","unstructured":"Zhu H, Hu S, Li Y, Sun Y, Xiong X, Hu X, Chen J. Interleukins and ischemic stroke. Front Immunol, 2022, 13: 828447.","journal-title":"Front Immunol"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/JAD-200972","volume":"79","author":"Ibi D","year":"2021","unstructured":"Ibi D, Hirashima K, Kojima Y, Sumiya K, Kondo S, Yamamoto M, Ando T. Preventive effects of continuous betaine intake on cognitive                         impairment and aberrant gene expression in hippocampus of 3xTg mouse model                         of Alzheimer\u2019s disease. J Alzheimer Dis, 2021, 79: 639-652.","journal-title":"J Alzheimer Dis"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/1735-5362.371583","volume":"18","author":"Alipourfard F","year":"2023","unstructured":"Alipourfard F, Shajiee H, Nazari-Serenjeh F, Hojati V, Alirezaie M. Betaine attenuates oxidative stress and cognitive dysfunction in                         an amyloid \u03b2-induced rat model of Alzheimer\u2019s disease. Res Pharm Sci, 2023, 18: 270-278.","journal-title":"Res Pharm Sci"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"711396","DOI":"10.3389\/fnmol.2021.711396","volume":"14","author":"Scholefield M","year":"2021","unstructured":"Scholefield M, Church SJ, Xu J, Patassini S, Roncaroli F, Hooper NM, Unwin RD. Severe and regionally widespread increases in tissue urea in the                         human brain represent a novel finding of pathogenic potential in Parkinson\u2019s                         disease dementia. Front Mol                             Neurosci, 2021, 14: 711396.","journal-title":"Front Mol                             Neurosci"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","volume":"15","author":"Polis B","year":"2018","unstructured":"Polis B, Srikanth KD, Elliott E, Gil-Henn H, Samson AO. L-norvaline reverses cognitive decline and synaptic loss in a                         murine model of Alzheimer\u2032s disease. Neurotherapeutics, 2018, 15: 1036-1054.","journal-title":"Neurotherapeutics"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jacc.2020.12.027","volume":"77","author":"Cortes-Canteli M","year":"2021","unstructured":"Cortes-Canteli M, Gispert JD, Salvad\u00f3 G, Toribio-Fernandez R, Trist\u00e3o-Pereira C, Falcon C, Oliva B. Subclinical atherosclerosis and brain metabolism in middle-aged                         individuals. J Am Coll                             Cardiol, 2021, 77: 888-898.","journal-title":"J Am Coll                             Cardiol"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.3390\/ijms19113479","volume":"19","author":"Getz GS","year":"2018","unstructured":"Getz GS, Reardon CA. Apoprotein E and reverse cholesterol transport. Int J Mol Sci, 2018, 19: 3479.","journal-title":"Int J Mol Sci"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1126\/science.272.5262.685","volume":"272","author":"Breslow JL","year":"1996","unstructured":"Breslow JL. Mouse models of atherosclerosis. Science, 1996, 272: 685-688.","journal-title":"Science"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.arr.2018.10.002","volume":"48","author":"Wang R","year":"2018","unstructured":"Wang R, Holsinger RMD. Exercise-induced brain-derived neurotrophic factor expression:                         therapeutic implications for Alzheimer\u2019s dementia. Ageing Res Rev, 2018, 48: 109-121.","journal-title":"Ageing Res Rev"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1038\/s41598-023-29894-1","volume":"13","author":"Sugiyama S","year":"2023","unstructured":"Sugiyama S, Sasaki T, Tanaka H, Yan H, Ikegami T, Kanki H, Nishiyama K. The tight junction protein occludin modulates blood-brain barrier                         integrity and neurological function after ischemic stroke in mice. Sci Rep, 2023, 13: 2892.","journal-title":"Sci Rep"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0169-328X(02)00647-2","volume":"110","author":"Burns MP","year":"2003","unstructured":"Burns MP, Noble WJ, Olm V, Gaynor K, Casey E, LaFrancois J, Wang L. Co-localization of cholesterol, apolipoprotein E and fibrillar A\u03b2                         in amyloid plaques. Mol Brain                             Res, 2003, 110: 119-125.","journal-title":"Mol Brain                             Res"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jep.2007.08.002","volume":"114","author":"Li CQ","year":"2007","unstructured":"Li CQ, He LC, Dong HY, Jin JQ. Screening for the anti-inflammatory activity of fractions and                         compounds from Atractylodes macrocephala Koidz. J EthnoPharmacol, 2007, 114: 212-217.","journal-title":"J EthnoPharmacol"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2021.09.013","volume":"12","author":"Liu W","year":"2022","unstructured":"Liu W, Li Z, Chu S, Ma X, Wang X, Jiang M, Bai G. Atractylenolide-I covalently binds to CYP11B2, selectively                         inhibits aldosterone synthesis, and improves hyperaldosteronism. Acta Pharm Sin                             B, 2022, 12: 135-148.","journal-title":"Acta Pharm Sin                             B"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00018-016-2379-7","volume":"74","author":"Shah SZA","year":"2017","unstructured":"Shah SZA, Hussain T, Zhao D, Yang L. A central role for calcineurin in protein misfolding                         neurodegenerative diseases. Cell Mol Life                             Sci, 2017, 74: 1061-1074.","journal-title":"Cell Mol Life                             Sci"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/nu9050451","volume":"9","author":"More S","year":"2017","unstructured":"More S, Choi DK. Neuroprotective role of atractylenolide-I in an in vitro                         and in vivo model of Parkinson\u2019s disease. Nutrients, 2017, 9: 451.","journal-title":"Nutrients"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12967-021-02727-3","volume":"19","author":"Zhang X","year":"2021","unstructured":"Zhang X, Qin Y, Wan X, Liu H, Lv C, Ruan W, He L. Rosuvastatin exerts anti-atherosclerotic effects by improving                         macrophage-related foam cell formation and polarization conversion via                         mediating autophagic activities. J Transl Med, 2021, 19: 62.","journal-title":"J Transl Med"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","volume":"1842","author":"Trushina E","year":"2014","unstructured":"Trushina E, Mielke MM. Recent advances in the application of metabolomics to Alzheimer\u2019s                         disease. Biochim                             Biophys Acta Mol Basis Dis, 2014, 1842: 1232-1239.","journal-title":"Biochim                             Biophys Acta Mol Basis Dis"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","volume":"34","author":"Gueli MC","year":"2013","unstructured":"Gueli MC, Taibi G. Alzheimer\u2019s disease: amino acid levels and brain metabolic status. Neurol Sci, 2013, 34: 1575-1579.","journal-title":"Neurol Sci"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"e2307256","DOI":"10.1002\/advs.202307256","volume":"11","author":"Cao X","year":"2024","unstructured":"Cao X, Wu VWY, Han Y, Hong H, Wu Y, Kong APS, Lui KO. Role of argininosuccinate synthase 1-dependent L-arginine                         biosynthesis in the protective effect of endothelial sirtuin 3 against                         atherosclerosis. Adv Sci, 2024, 11: e2307256.","journal-title":"Adv Sci"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"102139","DOI":"10.1016\/j.arr.2023.102139","volume":"92","author":"Zinellu A","year":"2023","unstructured":"Zinellu A, Tommasi S, Sedda S, Mangoni AA. Circulating arginine metabolites in Alzheimer\u2019s disease and                         vascular dementia: a systematic review and meta-analysis. Ageing Res Rev, 2023, 92: 102139.","journal-title":"Ageing Res Rev"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","volume":"137","author":"Morris Jr SM","year":"2007","unstructured":"Morris Jr SM. Arginine metabolism: boundaries of our knowledge. J Nutr, 2007, 137: 1602S-1609S.","journal-title":"J Nutr"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jnutbio.2005.12.001","volume":"17","author":"Jobgen WS","year":"2006","unstructured":"Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. Regulatory role for the arginine-nitric oxide pathway in                         metabolism of energy substrates. J Nutral                             Biochem, 2006, 17: 571-588.","journal-title":"J Nutral                             Biochem"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/biof.1099","volume":"39","author":"Dai Z","year":"2013","unstructured":"Dai Z, Wu Z, Yang Y, Wang J, Satterfield MC, Meininger CJ, Bazer FW. Nitric oxide and energy metabolism in mammals. Biofactors, 2013, 39: 383-391.","journal-title":"Biofactors"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/90C112BDDCBD4CC486717718BC3CCE87","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026055","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/90C112BDDCBD4CC486717718BC3CCE87","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:06:43Z","timestamp":1779260803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,24]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2026055","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}